FDA Adverse Event Death Summary report: N

ANGIOJET® ULTRA PE

MDR report key: 6912050 · Received October 3, 2017

Report

Report Number
2134265-2017-09617
Event Type
Death
Date Received
October 3, 2017
Date of Event
September 8, 2017
Report Date
September 11, 2017
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
DXE
PMA / PMN Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GB
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION. IF THERE IS ANY FURTHER RELEVANT INFORMATION OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT DIED POST-PROCEDURE. AN ANGIOJET® ULTRA PE CATHETER WAS USED FOR A PHARMOMECHANICAL THROMBECTOMY TREATMENT PROCEDURE OF A PULMONARY EMBOLUS. DURING THE PROCEDURE THE CATHETER WAS NOTED TO BE LEAKING INTO THE CONSOLE. THERE WERE NO REPORTED PATIENT COMPLICATIONS DURING THE PROCEDURE; HOWEVER IT WAS REPORTED THAT THE PATIENT IS NOW DECEASED. ADDITIONAL INFORMATION HAS BEEN REQUESTED BUT HAS NOT BEEN ABLE TO BE OBTAINED AT THE TIME OF THIS REPORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
691425 ANGIOJET® ULTRA PE CATHETER, EMBOLECTOMY DXE BOSTON SCIENTIFIC - MAPLE GROVE 107171-003 19242430

Patients

Seq Age Sex Outcome Treatment
1 Death